Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 1b Study of Andecaliximab in Participants With Spinal Cord Injury at Risk of Developing Heterotopic Ossification

This is an open-label study of andecaliximab in participants at risk of developing bone where bone should not be, such as in muscle, tendons, and other soft ti…

Heterotopic Ossification (HO)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ashibio IncNCT07024407